JOANNA BRANHAM: Open Payments
NPI 1033637244 · HILLSDALE, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,291 in 123 payments from 28 companies in 2025. Trend: 2023 $1,388 · 2024 $1,438 · 2025 $2,291
Food & beverage: $2,291
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 19 | $476 |
| Novo Nordisk Inc | 22 | $331 |
| ABBVIE INC. | 21 | $238 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 8 | $185 |
| Lundbeck LLC | 9 | $142 |
| Amgen Inc. | 5 | $102 |
| GlaxoSmithKline, LLC. | 3 | $68 |
| Regeneron Healthcare Solutions, Inc. | 3 | $64 |
| Boston Scientific Corporation | 3 | $63 |
| PFIZER INC. | 3 | $58 |
Products named: AIRSUPRA, CAPLYTA, Ozempic, REXULTI, Wegovy, FARXIGA, VRAYLAR, DUPIXENT.
Industry payments across MI — which companies pay providers there.
